The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients

References

• TysonGL, El-SeragHB. Risk factors for cholangiocarcinoma. Hepatology. 2011;54:173–184. doi:10.1002/hep.2435121488076
   PubMed Web of Science ®Google Scholar
• RizviS, GoresGJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145:1215–1229.24140396
   PubMed Web of Science ®Google Scholar
• KhanSA, EmadossadatyS, LadepNG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?J Hepatol. 2012;56:848–854. doi:10.1016/j.jhep.2011.11.01522173164
   PubMed Web of Science ®Google Scholar
• RaoofM, SinghG. Rising trends in intrahepatic cholangiocarcinoma incidence and mortality: getting at the root cause. Hepatobiliary Surg Nutr. 2019;8:301–303. doi:10.21037/hbsn.2019.01.1531245420
   PubMed Web of Science ®Google Scholar
• JarnaginWR, FongY, DeMatteoRP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507. doi:10.1097/00000658-200110000-0001011573044
   PubMed Web of Science ®Google Scholar
• de JongMC, MarquesH, ClaryBM, et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer. 2012;118:4737–4747. doi:10.1002/cncr.2749222415526
   PubMed Web of Science ®Google Scholar
• RizviS, KhanSA, HallemeierCL, KelleyRK, GoresGJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95–111. doi:10.1038/nrclinonc.2017.15728994423
   PubMed Web of Science ®Google Scholar
• McLeanL, PatelT. Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int. 2006;26:1047–1053.17032404
   PubMed Web of Science ®Google Scholar
• DiakosCI, CharlesKA, McMillanDC, ClarkeSJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493–503. doi:10.1016/S470-2045(14)70263-325281468
   PubMed Web of Science ®Google Scholar
• HaH, NamAR, BangJH, et al. Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy. Oncotarget. 2016;7:76604–76612. doi:10.18632/oncotarget.281027780932
   PubMedGoogle Scholar
• JinH, PangQ, LiuH, et al. Prognostic value of inflammation-based markers in patients with recurrent malignant obstructive jaundice treated by reimplantation of biliary metal stents: a retrospective observational study. Medicine. 2017;96:e5895. doi:10.1097/MD.000000000000589528099348
   PubMed Web of Science ®Google Scholar
• QiQ, ZhuangL, ShenY, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122:2158–2167. doi:10.1002/cncr.3005727152949
   PubMed Web of Science ®Google Scholar
• LiS, LanX, GaoH, et al. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J Cancer Res Clin Oncol. 2017;143:2455–2468. doi:10.1007/s00432-017-2506-328828692
   PubMed Web of Science ®Google Scholar
• GengY, ZhuD, WuC, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2018;65:503–510. doi:10.1016/j.intimp.2018.10.00230408627
   PubMed Web of Science ®Google Scholar
• ChenY, JiangW, XiD, et al. Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas. J Investig Med. 2019;67:691–698. doi:10.1136/jim-2018-000801
   PubMed Web of Science ®Google Scholar
• World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81:14–18.25951678
   PubMedGoogle Scholar
• EdgeSB, ComptonCC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–1474.20180029
   PubMed Web of Science ®Google Scholar
• CampRL, Dolled-FilhartM, RimmDL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–7259. doi:10.1158/078-0432.CCR-04-71315534099
   PubMed Web of Science ®Google Scholar
• VickersAJ, ElkinEB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26:565–574. doi:10.1177/0272989X0629536117099194
   PubMed Web of Science ®Google Scholar
• SahaSK, ZhuAX, FuchsCS, BrooksGA. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: intrahepatic Disease on the Rise. Oncologist. 2016;21:594. doi:10.1634/theoncologist.2015-044627000463
   PubMed Web of Science ®Google Scholar
• YangJD, KimB, SandersonSO, et al. Biliary tract cancers in Olmsted County, Minnesota, 1976–2008. Am J Gastroenterol. 2012;107:1256–1262.22751468
   PubMed Web of Science ®Google Scholar
• RazumilavaN, GoresGJ. Cholangiocarcinoma. Lancet. 2014;383:2168–2179. doi:10.1016/S0140-6736(13)61903-024581682
   PubMed Web of Science ®Google Scholar
• AntwiSO, PatelT. Increasing mortality of intrahepatic cholangiocarcinoma in the US: are gender-specific risk factors important?Hepatobiliary Surg Nutr. 2019;8:635. doi:10.21037/hbsn.2019.10.1031929993
   PubMed Web of Science ®Google Scholar
• HanahanD, WeinbergRA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• FerroneC, DranoffG. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol. 2010;28:4045–4051. doi:10.1200/JCO.2010.27.999220644090
   PubMed Web of Science ®Google Scholar
• RosenbergSA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411:380–384. doi:10.1038/3507724611357146
   PubMed Web of Science ®Google Scholar
• FranklinRA, LiaoW, SarkarA, et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344:921–925. doi:10.1126/science.125251024812208
   PubMed Web of Science ®Google Scholar
• ShibutaniM, MaedaK, NagaharaH, et al. The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study. BMC Cancer. 2017;17:404. doi:10.1186/s12885-017-3395-128583114
   PubMed Web of Science ®Google Scholar
• KusumantoYH, DamWA, HospersGA, MeijerC, MulderNH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6:283–287. doi:10.1023/B:AGEN.0000029415.62384.ba15166496
   PubMedGoogle Scholar
• MüllerI, MunderM, KropfP, HänschGM. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?Trends Immunol. 2009;30:522. doi:10.1016/j.it.2009.07.00719775938
   PubMed Web of Science ®Google Scholar
• LiuS, LiN, YuX, et al. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells. Gastroenterology. 2013;144:1031–41.e10.23376424
   PubMed Web of Science ®Google Scholar